WHO ICTRP trial
A study that evaluates the effectiveness of oral medicinal cannabis for people…
ACTRN12618001220257 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12618001220257 |
|---|---|
| Public title | A study that evaluates the effectiveness of oral medicinal cannabis for people with advanced cancer experiencing a range of symptoms. |
| Scientific title | Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: a double-blind, placebo controlled, randomised clinical trials of efficacy and safety of cannabidiol (CBD) |
| Primary sponsor | Mater Misericordiae Limited |
| Secondary sponsors | Mater Misericordiae Limited |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Cancer;Fatigue;Nausea;Breathlessness;Appetite;Psychological effects; Cancer Fatigue Nausea Breathlessness Appetite Psychological effects;Cancer - Any cancer |
| Interventions | Patients with advanced cancer will participate in a double-blind, placebo controlled, and randomisation clinical trial. Each participant will follow a dose titration schedule for 14 days and a follow on stable dose for a further 14 days… |
| Registration date | Jul 20, 2018 |
| Target size | 144 |
| Secondary IDs | NIL |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: